piracetam has been researched along with ubiquinone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, Y; Inukai, T; Kometani, M; Nakao, N; Okada, M; Takemori, E | 1 |
| Hadler, D; Schaffler, K; Stark, M | 1 |
| Bigal, ME; Rapoport, AM | 1 |
| Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G | 1 |
1 review(s) available for piracetam and ubiquinone
| Article | Year |
|---|---|
Migraine preventive therapy: current and emerging treatment options.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Calcium Channel Blockers; Coenzymes; Drug Therapy; Humans; Levetiracetam; Lisinopril; Migraine Disorders; Petasites; Piperazines; Piracetam; Preventive Medicine; Triazoles; Ubiquinone | 2005 |
1 trial(s) available for piracetam and ubiquinone
| Article | Year |
|---|---|
Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug.
Topics: Adult; Antioxidants; Benzoquinones; Dose-Response Relationship, Drug; Electrophysiology; Electroretinography; Evoked Potentials, Auditory; Humans; Hypoxia, Brain; Male; Nootropic Agents; Piracetam; Psychometrics; Ubiquinone | 1998 |
2 other study(ies) available for piracetam and ubiquinone
| Article | Year |
|---|---|
Effect of oxiracetam on cerebrovascular impairment in rats.
Topics: Animals; Behavior, Animal; Benzoquinones; Blood Pressure; Cerebral Arteries; Cerebral Infarction; Cerebrovascular Disorders; Electroencephalography; Male; Motor Activity; Norepinephrine; Piracetam; Pyrrolidines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Tranylcypromine; Ubiquinone | 1991 |
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Levetiracetam; MERRF Syndrome; Middle Aged; Mitochondria; Muscle, Skeletal; Mutation; Myoclonus; Phenylalanine; Piracetam; Quality of Life; RNA, Transfer; Treatment Outcome; Ubiquinone; Valproic Acid | 2006 |